Effect of Rapamycin in Ovarian Aging

Summary

The investigators are proposing a prospective, randomized, double-blind, placebo-controlled pilot study assessing the ability of low-dose rapamycin to delay ovarian aging in women. Animal studies have shown the potential of rapamycin in slowing or reversing some age-associated pathways.

Timeline

Start

2023-06-01

Primary completion

2025-10-21

Completion

2026-09

Drugs

Indications